Incidence of serious adverse events caused by tyrosine kinase inhibitor treatment following immune checkpoint inhibitor therapy in advanced NSCLC patients with oncogenic driver alterations

被引：0
|
作者：
Yukiko Shimoda
Tatsuya Yoshida
Jun Miyakoshi
Masahiro Torasawa
Akiko Tateishi
Yuji Matsumoto
Ken Masuda
Yuki Shinno
Yusuke Okuma
Yasushi Goto
Hidehito Horinouchi
Noboru Yamamoto
Yuichiro Ohe
机构：
[1] National Cancer Center Hospital,Department of Thoracic Oncology
[2] National Cancer Center Hospital,Department of Experimental Therapeutics
来源：
Cancer Immunology, Immunotherapy | 2023年 / 72卷
关键词：
Non-small cell lung cancer; Sequential therapy; Dosing interval; Serious adverse events;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2613 / 2621
页数：8
相关论文
共 50 条
  • [21] Meta-analysis of immune-related adverse events of immune checkpoint inhibitor therapy in cancer patients
    Song, Peng
    Zhang, Dingding
    Cui, Xiaoxia
    Zhang, Li
    THORACIC CANCER, 2020, 11 (09) : 2406 - 2430
  • [22] Adverse Events and Outcomes in Patients with Oncogenic Driver Mutation-positive NSCLC Receiving Targeted Therapy Following Immunotherapy
    Dean, M. L.
    Gibson, A. J. W.
    Box, A. H.
    Cheung, W. Y.
    Navani, V.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S679 - S680
  • [23] Distinct Immune Signatures Indicative of Treatment Response and Immune-Related Adverse Events in Melanoma Patients under Immune Checkpoint Inhibitor Therapy
    Reschke, Robin
    Gussek, Philipp
    Boldt, Andreas
    Sack, Ulrich
    Koehl, Ulrike
    Lordick, Florian
    Gora, Thomas
    Kreuz, Markus
    Reiche, Kristin
    Simon, Jan-Christoph
    Ziemer, Mirjana
    Kunz, Manfred
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (15)
  • [24] The Incidence of Tissue-Proven Immune-Related Adverse Events in Surgical Resections and Biopsies of Patients Undergoing Checkpoint Inhibitor Therapy
    Rehman, Jamaal
    Hall, Curtis
    MODERN PATHOLOGY, 2019, 32
  • [25] The Incidence of Tissue-Proven Immune-Related Adverse Events in Surgical Resections and Biopsies of Patients Undergoing Checkpoint Inhibitor Therapy
    Rehman, Jamaal
    Hall, Curtis
    LABORATORY INVESTIGATION, 2019, 99
  • [26] AUTOANTIBODY BIOMARKERS OF IMMUNE-RELATED ADVERSE EVENTS AND SURVIVAL IN MELANOMA PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITOR THERAPY
    Aude, C.
    Ghosh, N.
    Jannat-Khah, D.
    Chan, K. K.
    Postow, M.
    Larman, H.
    Bass, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1188 - 1189
  • [27] Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update
    Schneider, Bryan J.
    Naidoo, Jarushka
    Santomasso, Bianca D.
    Lacchetti, Christina
    Adkins, Sherry
    Anadkat, Milan
    Atkins, Michael B.
    Brassil, Kelly J.
    Caterino, Jeffrey M.
    Chau, Ian
    Davies, Marianne J.
    Ernstoff, Marc S.
    Fecher, Leslie
    Ghosh, Monalisa
    Jaiyesimi, Ishmael
    Mammen, Jennifer S.
    Naing, Aung
    Nastoupil, Loretta J.
    Phillips, Tanyanika
    Porter, Laura D.
    Reichner, Cristina A.
    Seigel, Carole
    Song, Jung-Min
    Spira, Alexander
    Suarez-Almazor, Maria
    Swami, Umang
    Thompson, John A.
    Vikas, Praveen
    Wang, Yinghong
    Weber, Jeffrey S.
    Funchain, Pauline
    Bollin, Kathryn
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (36) : 4073 - +
  • [28] Characterization and Prognostic Significance of Cutaneous Immune-Related Adverse Events in Indian Patients on Immune Checkpoint Inhibitor Therapy
    Duraisamy, Prasanna
    Panicker, Vinitha Varghese
    Jose, Wesley Mannirathil
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2023, 13 (03):
  • [29] Associations between Immune-related Adverse Events and Prognosis in Cancer Patients Receiving Immune Checkpoint Inhibitor Therapy
    Inoue, Yusuke
    Inui, Naoki
    INTERNAL MEDICINE, 2024,
  • [30] Prevalence, therapy and tumour response in patients with rheumatic immune-related adverse events following immune checkpoint inhibitor therapy: a single-centre analysis
    Verspohl, Sophia H.
    Holderried, Tobias
    Behning, Charlotte
    Brossart, Peter
    Schaefer, Valentin S.
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2021, 13
12345